Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9599 posts found.

ReNeuron’s ground-breaking stem cell trial approved

January 22, 2009 Research and Development ReNeuron, stem cell

 UK biotech ReNeuron has been given the go-ahead for a ground-breaking stem cell clinical trial.The phase I trial of its …
News

UK Biotech: time for bold and affirmative action

January 22, 2009 Research and Development, Sales and Marketing BTG, Chris Collins, Christopher Evans, Neuropharm, Plethora, UK, biotech, pharma, strategy

Biotech leaders in the UK say the cash-stricken industry has reached ‘breaking point’, and have made an unprecedented plea for …
Feature

Pfizer announces R&D job losses

January 15, 2009 Research and Development Pfizer

Jobs losses at Pfizer's research and development centre in Sandwich, Kent look a certainty after the company announced cutbacks to …
News

A postcard from … Spain

January 14, 2009 Research and Development, Sales and Marketing Spain, healthcare, pharma

Feature

Wellcome Trust backs epigenetics project

January 13, 2009 Research and Development epigenetics

A public-private partnership aiming to determine the three-dimensional structure of medically-relevant proteins and put them in the public domain has …
News

Getting up to speed with India

January 12, 2009 Research and Development India, clinical trials, ethics

On a recent trip I made to India, the resourcefulness of the country's people was demonstrated to me as soon …
Feature

UK biotech forced to hang on for government aid

January 9, 2009 Research and Development biotech

Cash-stricken UK biotech has been left hanging on for government funding, without any guarantee it will get the support needed. …
News

Novartis boosts vaccine pipeline

January 8, 2009 Research and Development, Sales and Marketing Novartis, recruitment, vaccines

Novartis has added an investigational vaccine to its pipeline through a $20 million deal with AlphaVax. The North Carolina-based biotech …
News

Pfizer to develop vaccines with Cytos

January 8, 2009 Research and Development, Sales and Marketing Cytos, Pfizer

News

Working Life: Les Hughes

January 8, 2009 Research and Development AstraZeneca, Cancer, clinical research, infection

How did you find your way into your role? I wanted to be a chemist from my very first experience …
Feature

Biotech in 2008

December 31, 2008 Research and Development Genentech, InClone, biotech, economy, investment

The credit crunch hits biotechBy October Europe's biotech sector was feeling severe effects from the credit crunch, with small and …
Feature

2008: A year in the life of UK pharma

December 31, 2008 Research and Development, Sales and Marketing 2008, YIR, patients, pharma, review, social networking, year in review

  Patient power proves decisive in battle for accessSocial networking helped a new breed of informed patient advocates win the …
Feature

Lilly to reduce pipeline costs by a third

December 17, 2008 Research and Development lilly, restructure

Lilly aims to reduce the cost of it bringing new molecules to market by a third.The company's goal is to …
News

Declaring doctor payments

December 16, 2008 Research and Development, Sales and Marketing ABPI, EFPIA, Europe, UK, US, ethics, industry relations, payments

A number of pharmaceutical companies in the US have recently announced they will declare all the payments to healthcare professionals. …
Feature

UK biotech seeks bail out

December 9, 2008 Research and Development biotech

Biotech leaders in the UK say the cash-stricken industry has reached 'breaking point', and have made an unprecedented plea for …
News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026